Related Experiment Video
Updated: Oct 17, 2025

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders
Jesús Porcuna1, Jorge Mínguez-Martínez1, Mercedes Ricote1
1Myocardial Pathophisiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain.
Abstract:
Peroxisome proliferator-activated receptors (PPARs) are ligand-modulated nuclear receptors that play pivotal roles in nutrient sensing, metabolism, and lipid-related processes. Correct control of their target genes requires tight regulation of the expression of different PPAR isoforms in each tissue, and the dysregulation of PPAR-dependent transcriptional programs is linked to disorders, such as metabolic and immune diseases or cancer. Several PPAR regulators and PPAR-regulated factors are epigenetic effectors, including non-coding RNAs, epigenetic enzymes, histone modifiers, and DNA methyltransferases. In this review, we examine advances in PPARα and PPARγ-related epigenetic regulation in metabolic disorders, including obesity and diabetes, immune disorders, such as sclerosis and lupus, and a variety of cancers, providing new insights into the possible therapeutic exploitation of PPAR epigenetic modulation.
Insights
Peroxisome proliferator-activated receptors (PPARs) regulate metabolism and are implicated in diseases. Epigenetic mechanisms, involving non-coding RNAs and enzymes, offer potential therapeutic targets for metabolic, immune, and cancerous conditions.
Area of Science:
- Molecular biology
- Epigenetics
- Metabolic research
Background:
- Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors crucial for nutrient sensing, metabolism, and lipid processes.
- Dysregulation of PPAR-dependent gene expression is linked to metabolic diseases, immune disorders, and cancer.
- Epigenetic factors, including non-coding RNAs and enzymes, influence PPAR activity.
Purpose of the Study:
- To review advances in the epigenetic regulation of PPARα and PPARγ.
- To explore the role of PPAR epigenetic modulation in metabolic disorders, immune diseases, and cancer.
- To provide insights into potential therapeutic strategies targeting PPAR epigenetic pathways.
Main Methods:
- Literature review of studies on PPARα and PPARγ epigenetic regulation.
- Analysis of research linking epigenetic modifications to PPAR function in disease.
- Synthesis of findings on therapeutic exploitation of PPAR epigenetic modulation.
Main Results:
- Epigenetic regulators like non-coding RNAs, enzymes, histone modifiers, and DNA methyltransferases are key in PPAR pathways.
- PPAR epigenetic modulation is implicated in obesity, diabetes, sclerosis, lupus, and various cancers.
- Specific epigenetic mechanisms offer novel therapeutic avenues for PPAR-related diseases.
Conclusions:
- Epigenetic control of PPARs is critical for maintaining metabolic and immune homeostasis.
- Targeting PPAR epigenetic modulation presents a promising therapeutic strategy for a range of diseases.
- Further research into PPAR epigenetic mechanisms can unlock new treatments for metabolic, immune, and oncological conditions.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Global Regulatory Systems
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Cell Specific Gene Expression
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

